CDK4 and neoplasm: Our results were consistent with those from in vivo experiments, that is, dramatic decreases in class I HDACs, CDK4, cyclin D1, Ki-67, and EMT-promoted protein expression and increased p21 and E-cadherin expression in tumor tissues of mice treated with magnolol or MM1 (Figures 6G,H).